News Room

Recently, the list of 2023 “Science and Technology Innovation Action Plan - Technology Giant Program” in Shanghai was officially released, with Shanghai Zerun Biotech being honored as a “Shanghai Technology Giant (Incubation)” enterprise.

The Technology Giant Program targets high-tech enterprises engaged in the development, production, and commercialization of products and technical services aligned with national and municipal industrial development strategies. These enterprises are characterized by strong innovation capabilities, competitive market advantages, and high growth potential. Key qualifications include:

A well-established innovation system and R&D investment mechanism;

Proprietary branded products with significant market share in their niche sectors;

Established economic scale and promising growth trajectory;

Strong creditworthiness and financing capacity.

The designation reflects innovation leadership, scalability, and industry exemplariness.

Being recognized as a “Shanghai Technology Giant (Incubation)” enterprise underscores Shanghai Zerun's achievements in scientific innovation, market competitiveness, and future potential, while also setting higher expectations for its growth. The company will leverage this milestone to intensify R&D and innovation investments, further strengthening its core competitiveness and contributing to industry advancement.